Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Dominovas Energy Corporation (DNRG) Appoints Special Advisor to Oversee Renewable Energy Projects in Sub-Saharan Africa

Late last week, Dominovas Energy Corporation (OTCQB: DNRG) announced the appointment of Dr. Emma Rasolovoahangy to the position of ambassador for renewable energy projects and special advisor for the Republic of Madagascar. Following this announcement, Rasolovoahangy will immediately assume responsibility for the company’s ongoing renewable energy projects in sub-Saharan Africa, particularly as they relate to […]

Monaker Group’s (MKGI) NextTrip Platform Destinations in Line with U.S. Travel Trends this Fall

Americans’ travel habits and destinations are changing, as this fall’s trends show a significant increase among alternative destinations such as Cuba and South Africa, according to a recent survey (http://nnw.fm/lNf8N) by leading travel insurance comparison site Squaremouth. The changes are largely due to U.S. tourists’ growing concerns about terrorism, which have led to a major […]

Sully Discovery by Star Mountain Resources, Inc. (SMRS) Confirms Richness of Balmat Mine Host Rock

The announcement by Star Mountain Resources, Inc. (OTC: SMRS) of the Sully discovery validates the company’s decision to reactivate the Balmat mine. The company’s recently completed district-wide review and evaluation, which targeted zinc mineralization in the Balmat-Edwards Mining District of St. Lawrence County, New York, yielded encouraging results. The review identified significant potential zinc mineralization, […]

Development of CorMedix, Inc.’s (CRMD) Bloodstream Infection Therapy on Pace for Regulatory Approval

Catheter-related bloodstream infections (CRBSIs) are one of the most frequently encountered types of infections contracted in hospital units, resulting in billions of dollars in additional expenses for the U.S. healthcare system every year. It is estimated that there are roughly 250,000 CRBSIs every year, a third of them reported in ICUs. These infections lead to […]

 

From Our Blog

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Clinical and Regulatory Milestones

July 28, 2026

Cartilage Regeneration Gains Strategic Validation The orthopedic industry is increasingly focused on technologies that can address cartilage damage by promoting tissue regeneration rather than simply managing symptoms. This opportunity gained additional validation when Smith+Nephew completed its acquisition of CartiHeal, a developer of cartilage repair technology, in a transaction valued at up to $330 million. The […]

Rotate your device 90° to view site.